Tulobuterol HCL powder (56776-01-3) Manufacturers & Suppliers - Factory

Tulobuterol HCL (56776-01-3)

June 24, 2019
5.00 out of 5 based on 1 customer rating

Tulobuterol HCL (56776-01-3) is a long-acting beta2-adrenergic receptor agonist. Tulobuterol has almost no effects on blood pressure and heart rate and is highly selective for the tracheal muscle. It is indicated to improve symptoms such as respiratory distress caused by airway obstruction of bronchial asthma, bronchitis, chronic obstructive pulmonary disease (COPD) and emphysema.

 


Status: In Mass Production
Unit: 25kg/Drum

Tulobuterol HCL (56776-01-3) video

Tulobuterol HCL (56776-01-3)Description

Tulobuterol HCL (56776-01-3) is a long-acting beta2-adrenergic receptor agonist. Tulobuterol has almost no effects on blood pressure and heart rate and is highly selective for the tracheal muscle. It is indicated to improve symptoms such as respiratory distress caused by airway obstruction of bronchial asthma, bronchitis, chronic obstructive pulmonary disease (COPD) and emphysema. Serious side effects detected were: tremor, palpitations and serum potassium level decrease.

 

Tulobuterol HCL (56776-01-3)Specifications

Product Name Tulobuterol HCL
Chemical Name 2-(tert-Butylamino)-1-(2-chlorophenyl)ethanol hydrochloride
Brand Name Tulobuterol Hydrochloride
Drug Class beta2-adrenergic receptor agonist
CAS Number 56776-01-3
InChIKey RSLNRVYIRDVHLY-UHFFFAOYSA-N
Molecular Formula C12H19Cl2NO
Molecular Weight 264.19
Monoisotopic Mass 263.0844 g/mol
Melting Point  159-164°C
Boiling Point 338.2 °C at 760 mmHg
Biological Half-Life N/A
Color White powder
Solubility  Soluble in DMSO
Storage Temperature  0 – 4 C for short term (days to weeks), or -20 C for long term (months)
Application Tulobuterol HCL is a long-acting beta2-adrenergic receptor agonist.

 


=

References & product citations